Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jumei Shi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[Myeloma cancer stem cells:the new target for multiple myeloma]Lu Gao, Fenghuang Zhan, Jumei Shi
Cancer Medicine|March 12, 2020
Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt LymphomaYi Xie, Mengyu Jia, Jumei Shi, et al.
Biomed Research International|May 23, 2015
Smoldering multiple myelomaMinjie Gao, Guang Yang, Yuanyuan Kong, et al.
Oncology Letters|January 4, 2020
Influence of demethylation on regulatory T and Th17 cells in myelodysplastic syndromeXinyan Jia, Wenzhong Yang, Xiaohui Zhou, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myelomaXiaosong Wu, Yi Tao, Jun Hou, et al.
Oncotarget|March 24, 2016
Multiple myeloma cancer stem cellsMinjie Gao, Yuanyuan Kong, Guang Yang, et al.
Plos One|July 5, 2013
Down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosisYi Tao, Lu Gao, Xiaosong Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 17, 2002
[Report of a patient with spontaneous aggregation of his giant and morphologically abnormal platelets]Zhaoyue Wang, Jumei Shi, Yue Han, et al.
Bioorganic Chemistry|July 23, 2024
TRIP13 - a potential drug target in cancer pharmacotherapySamuel Jacob Bunu, Haiyan Cai, Leyun Wu, et al.
Cancer Genetics|July 24, 2014
An ider(17)(q10)t(15;17) with spliced long-type PML-RARA fusion transcripts in a case of acute promyelocytic leukemiaXiaojing Hu, Gongwen Ai, Xiuqin Meng, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[Myeloma cancer stem cells:the new target for multiple myeloma]Lu Gao, Fenghuang Zhan, Jumei Shi
Cancer Medicine|March 12, 2020
Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt LymphomaYi Xie, Mengyu Jia, Jumei Shi, et al.
Biomed Research International|May 23, 2015
Smoldering multiple myelomaMinjie Gao, Guang Yang, Yuanyuan Kong, et al.
Oncology Letters|January 4, 2020
Influence of demethylation on regulatory T and Th17 cells in myelodysplastic syndromeXinyan Jia, Wenzhong Yang, Xiaohui Zhou, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myelomaXiaosong Wu, Yi Tao, Jun Hou, et al.
Oncotarget|March 24, 2016
Multiple myeloma cancer stem cellsMinjie Gao, Yuanyuan Kong, Guang Yang, et al.
Plos One|July 5, 2013
Down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosisYi Tao, Lu Gao, Xiaosong Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 17, 2002
[Report of a patient with spontaneous aggregation of his giant and morphologically abnormal platelets]Zhaoyue Wang, Jumei Shi, Yue Han, et al.
Bioorganic Chemistry|July 23, 2024
TRIP13 - a potential drug target in cancer pharmacotherapySamuel Jacob Bunu, Haiyan Cai, Leyun Wu, et al.
Cancer Genetics|July 24, 2014
An ider(17)(q10)t(15;17) with spliced long-type PML-RARA fusion transcripts in a case of acute promyelocytic leukemiaXiaojing Hu, Gongwen Ai, Xiuqin Meng, et al.
Pageof 9